Dr. Jonathan Adachi is a Professor of Medicine at the Michael G. DeGroote School of Medicine, McMaster University. He is the Actavis Chair for Better Bone Health in Rheumatology. Dr. Adachi has been involved in clinical trials and epidemiologic research. He either holds or is a co-investigator in several CIHR funded studies including the 20 year Canadian Multicentre Osteoporosis Study (CaMOS), and a separate study examining pQCT, HRpQCT and pMRI images of bone structure and strength to determine the relationship of bone structure and muscle to fractures in a subset of CaMOS subjects.
Dr Adachi has over 590 peer reviewed publications and is a respected leader in bone research in Canada and Internationally. He was awarded the Lindy Fraser Award by Osteoporosis Canada. In 2006, he received the North American Menopause Society award for Innovation in Osteoporosis Research. In 2012, he received the Queen Elizabeth II Diamond Jubilee Medal for his work in osteoporosis and in 2014 he was received the Olof Johnell Science Award that honours an individual who has contributed to the field of osteoporosis in a scientific or policy implementation area worldwide. In 2019 he was awarded the Herbert Fleisch Medal by ESCEO-IOF in recognition of his outstanding and innovative contributions in basic or translational science.
Dr. Angela M. Cheung is Professor of Medicine, KY and Betty Ho Chair in Integrative Medicine at University of Toronto (UT) and Senior Scientist at University Health Network (UHN). She is currently holding a Tier 1 Canada Research Chair in Musculoskeletal and Postmenopausal Health, and has held a Canadian Institutes of Health Research (CIHR) Senior Investigator award, the Canadian Society of Internal Medicine (CSIM) David Sackett Senior Investigator award, the Ontario Premier Research Award and the University of Toronto Eudenie Stuart Mentorship award. She is a member of the Endocrine Society Clinical Guidelines Committee, chair of the International Society of Clinical Densitometry Canadian Panel, and the past chair of Osteoporosis Canada Scientific Advisory Council. She obtained her M.D. degree from Johns Hopkins University School of Medicine in 1988, and her PhD degree from Harvard University in 1997. She is a Fellow of the Royal College of Physicians of Canada and has been in clinical practice for >30 years. Twitter @AngelaMCheung
Dr. Cummings is an Internal Medicine specialist and Professor of Medicine, Epidemiology, and Biostatistics at UC San Francisco. He is the Executive Director of the San Francisco Coordinating Center in the California Pacific Medical Center Research Institute. He is an internationally recognized expert on osteoporosis and prevention of fractures. He has led the large clinical trials that won FDA approval for most of the drug treatments for osteoporosis – Alendronate, Zoledronate, Denosumab, and Raloxifene. He has designed and led large longitudinal studies about risk factors for osteoporosis, including the Study of Osteoporotic Fractures for older women and MrOS for older men. He has published articles about the risk of fractures in patients with medical and neurolgic conditions, He has over 600 peer-reviewed publications and won several awards for his research in osteoporosis including ASBMR’s William Neuman Award for Outstanding and Major Scientific Contributions and Frederick Bartter Award for Excellence in Clinical Research in Bone and Mineral Research. He has also been elected to the prestigious National Academy of Medicine in the National Academy of Sciences for his contributions to Clinical Research.
Aliya Khan is a Professor of Clinical Medicine at McMaster University, Director of the Calcium Disorders Clinic and the Fellowship in Metabolic Bone Disease at McMaster University. She graduated from the University of Ottawa Medical School with honors and completed postgraduate training at the University of Toronto. She has published over 200 scientific papers and numerous chapters and books on osteoporosis and parathyroid disease. She has received numerous national and international awards including the Queen’s Diamond Jubilee Medal for excellence, International Hypoparathyroidism Award, International Osteoporosis Foundation award for publishing excellence and recognized by Osteoporosis Canada for outstanding contributions to research and education. She was recognized as being in the top 0.1% of the world experts in hyperparathyroidism by Expertscape.